In the early 1950s, a premature infant named Stevland Hardaway Judkins was placed in an incubator. The oxygen therapy intended to save his life caused his retinas to detach. He grew up to be Stevie Wonder, but he never saw the world he would eventually define through music. Today, that condition—retinopathy of prematurity, or ROP—is far more manageable. Yet, a troubling inconsistency remains.

In Norway, the rate at which hospitals treat ROP varies significantly. It shouldn't. Premature infants are biologically similar, regardless of which hospital they are born in. If the medical standards are uniform, the treatment rates should be, too. They are not.

"These differences between the hospitals are inexplicable," says Dordi Austeng, a professor at the Norwegian University of Science and Technology (NTNU). The medical community assumed the variation stemmed from the doctors themselves. Perhaps some ophthalmologists were simply more aggressive with treatment than others. It was a logical hypothesis. It was also wrong.

Testing the Specialists

To solve the mystery, Austeng and her colleagues conducted a study published in Acta Ophthalmologica. They recruited all 15 ophthalmologists in Norway responsible for diagnosing and treating ROP in infants. The goal was to determine if individual diagnostic thresholds were driving the regional disparities.

The doctors were asked to evaluate cases using a standardized testing platform developed with help from U.S. colleagues. If the "over-treatment" theory held water, the regions with the highest treatment rates would show the most lenient diagnostic criteria. The results were the opposite.

"The ophthalmologists in the region that treated the most children were most restrictive in making the diagnosis," Austeng explained. The doctors who treated the most infants were actually the most conservative in their clinical judgment. The mystery deepened.

Searching for the Root Cause

If the doctors aren't the variable, the patients must be. The research team is now shifting its focus toward the health of the infants themselves. Premature babies are fragile. They often battle infections, lung disease, and the long-term effects of oxygen therapy.

It is possible that some hospitals receive a higher concentration of the most vulnerable, "sicker" infants. If one hospital manages a higher-acuity population, they will naturally see more severe cases of ROP.

"We know that the most premature babies are sicker," says Tora Sund Morken, a professor in the Research Group for Ophthalmology at NTNU. "This can result in a higher proportion of children with eye disease and more serious eye disease that needs treatment."

The Data Trail

To confirm this, the team is turning to the Norwegian Neonatal Network. This database tracks every diagnosis and treatment intervention for newborns across the country. By cross-referencing ROP treatment rates with specific neonatal health indicators, the researchers hope to isolate the true drivers of the disparity.

Key Takeaways

  • Retinopathy of prematurity (ROP) remains a leading cause of preventable blindness in premature infants, though modern screening has drastically reduced its prevalence.
  • A national study of Norwegian ophthalmologists found that regional treatment variations are not caused by doctors being "too aggressive" with their diagnoses.
  • Researchers are now analyzing neonatal health data to determine if differences in infant survival rates and underlying health conditions explain the treatment gaps.

What Experts Say

Experts emphasize that while the current variation is concerning, the standard of care remains high. The primary goal of the ongoing research is to ensure that every infant, regardless of their location, receives the same evidence-based screening.

"We hope to find more answers this year," says Austeng. The team expects to conclude their data analysis by the end of 2025. Once the findings are published, the next step will be a national review of neonatal protocols to standardize care. For the families of the most vulnerable infants, the results of this data audit could mean the difference between a lifetime of sight and a lifetime of darkness.

This article is for informational purposes only. Always consult a qualified healthcare professional before making any medical decisions.